157 related articles for article (PubMed ID: 32935296)
1. MAGE-C2/CT10 promotes growth and metastasis through upregulating c-Myc expression in prostate cancer.
Qiu J; Yang B
Mol Cell Biochem; 2021 Jan; 476(1):1-10. PubMed ID: 32935296
[TBL] [Abstract][Full Text] [Related]
2. Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients.
Curioni-Fontecedro A; Nuber N; Mihic-Probst D; Seifert B; Soldini D; Dummer R; Knuth A; van den Broek M; Moch H
PLoS One; 2011; 6(6):e21418. PubMed ID: 21738656
[TBL] [Abstract][Full Text] [Related]
3. MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer.
von Boehmer L; Keller L; Mortezavi A; Provenzano M; Sais G; Hermanns T; Sulser T; Jungbluth AA; Old LJ; Kristiansen G; van den Broek M; Moch H; Knuth A; Wild PJ
PLoS One; 2011; 6(7):e21366. PubMed ID: 21754986
[TBL] [Abstract][Full Text] [Related]
4. Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2.
Zhuang R; Zhu Y; Fang L; Liu XS; Tian Y; Chen LH; Ouyang WM; Xu XG; Jian JL; Güre AO; Fortunato S; Ritter G; Old LJ; Simpson AJ; Chen YT; Jin B; Jungbluth AA
Cancer Immun; 2006 Apr; 6():7. PubMed ID: 16594646
[TBL] [Abstract][Full Text] [Related]
5. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
[TBL] [Abstract][Full Text] [Related]
6. MAGE-C1/CT7 and MAGE-C2/CT10 are frequently expressed in multiple myeloma and can be explored in combined immunotherapy for this malignancy.
de Carvalho F; Alves VL; Braga WM; Xavier CV; Colleoni GW
Cancer Immunol Immunother; 2013 Jan; 62(1):191-5. PubMed ID: 23180015
[TBL] [Abstract][Full Text] [Related]
7. Expression of cancer testis antigens CT10 (MAGE-C2) and GAGE in gastrointestinal stromal tumors.
Ghadban T; Perez DR; Vashist YK; Bockhorn M; Koenig AM; El Gammal AT; Izbicki JR; Metzger U; Hauswirth F; Frosina D; Jungbluth AA
Eur J Surg Oncol; 2014 Oct; 40(10):1307-12. PubMed ID: 24713551
[TBL] [Abstract][Full Text] [Related]
8. CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis.
Güre AO; Stockert E; Arden KC; Boyer AD; Viars CS; Scanlan MJ; Old LJ; Chen YT
Int J Cancer; 2000 Mar; 85(5):726-32. PubMed ID: 10699956
[TBL] [Abstract][Full Text] [Related]
9. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
10. A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer.
Hu Y; Wang F; Xu F; Fang K; Fang Z; Shuai X; Cai K; Chen J; Hu P; Chen D; Xu P; Hu C; Zeng Z; Zhong J; Li W; Tang J; Huang M; Zhao Y; Wang C; Zhao G
Theranostics; 2020; 10(22):10120-10140. PubMed ID: 32929338
[No Abstract] [Full Text] [Related]
11.
Umbreen S; Banday MM; Jamroze A; Mansini AP; Ganaie AA; Ferrari MG; Maqbool R; Beigh FH; Murugan P; Morrissey C; Corey E; Konety BR; Saleem M
Mol Cancer Ther; 2019 Nov; 18(11):2111-2123. PubMed ID: 31467179
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.
Pabst C; Zustin J; Jacobsen F; Luetkens T; Kröger N; Schilling G; Bokemeyer C; Sauter G; Atanackovic D; Marx A
Exp Mol Pathol; 2010 Oct; 89(2):175-81. PubMed ID: 20621094
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
Sun B; Fan Y; Yang A; Liang L; Cao J
J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
[TBL] [Abstract][Full Text] [Related]
14. PSCA promotes prostate cancer proliferation and cell-cycle progression by up-regulating c-Myc.
Li E; Liu L; Li F; Luo L; Zhao S; Wang J; Kang R; Luo J; Zhao Z
Prostate; 2017 Dec; 77(16):1563-1572. PubMed ID: 28971496
[TBL] [Abstract][Full Text] [Related]
15. MAGE-C2 promotes growth and tumorigenicity of melanoma cells, phosphorylation of KAP1, and DNA damage repair.
Bhatia N; Xiao TZ; Rosenthal KA; Siddiqui IA; Thiyagarajan S; Smart B; Meng Q; Zuleger CL; Mukhtar H; Kenney SC; Albertini MR; Jack Longley B
J Invest Dermatol; 2013 Mar; 133(3):759-767. PubMed ID: 23096706
[TBL] [Abstract][Full Text] [Related]
16. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
[TBL] [Abstract][Full Text] [Related]
17. R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize c-Myc.
Lin TP; Li J; Li Q; Li X; Liu C; Zeng N; Huang JM; Chu GC; Lin CH; Zhau HE; Chung LWK; Wu BJ; Shih JC
Mol Cancer Res; 2018 Dec; 16(12):1940-1951. PubMed ID: 30042175
[TBL] [Abstract][Full Text] [Related]
18. Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.
Yan Y; Zhou B; Qian C; Vasquez A; Kamra M; Chatterjee A; Lee YJ; Yuan X; Ellis L; Di Vizio D; Posadas EM; Kyprianou N; Knudsen BS; Shah K; Murali R; Gertych A; You S; Freeman MR; Yang W
Nat Commun; 2022 Feb; 13(1):669. PubMed ID: 35115556
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth.
Bindukumar B; Schwartz SA; Nair MP; Aalinkeel R; Kawinski E; Chadha KC
Neoplasia; 2005 Mar; 7(3):241-52. PubMed ID: 15799824
[TBL] [Abstract][Full Text] [Related]
20. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer.
Li X; Wu JB; Li Q; Shigemura K; Chung LW; Huang WC
Oncotarget; 2016 Mar; 7(11):12869-84. PubMed ID: 26883200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
